Alpha Tau Medical (NASDAQ: DRTS) to present at J.P. Morgan 2026 event

Rhea-AI Filing Summary

Alpha Tau Medical Ltd. submitted a Form 6-K noting that it issued a press release titled “Alpha Tau to Present at the J.P. Morgan 2026 Healthcare Conference.” The press release, dated December 18, 2025, is included as an exhibit to the report. The company clarifies that the information in this Form 6-K, including the exhibit, is being furnished rather than filed, which limits its potential liability under U.S. securities laws and controls how it may be incorporated into other regulatory documents.

UNITED STATES

SECURITIES AND EXCHANGE COMMISSION

Washington, D.C. 20549

FORM 6-K

REPORT OF FOREIGN PRIVATE ISSUER

PURSUANT TO SECTION 13A-16 OR 15D-16

UNDER THE SECURITIES EXCHANGE ACT OF 1934

For the month of December 2025

Commission File Number: 001-41316

Alpha Tau Medical Ltd.

(Exact Name of Registrant as Specified in Its Charter)

Kiryat HaMada St. 5

Jerusalem, Israel 9777605

+972 (3) 577-4115

(Address of principal executive offices)

Indicate by check mark whether the registrant files or will file annual reports under cover of Form 20-F or Form 40-F.

Form 20-F ☒        Form 40-F ☐

CONTENTS

On December 18, 2025, Alpha Tau Medical Ltd. (the “Company”) issued a press release titled “Alpha Tau to Present at the J.P. Morgan 2026 Healthcare Conference.” A copy of this press release is attached to this Form 6-K as Exhibit 99.1.

The information in this Report on Form 6-K, including Exhibit 99.1 attached hereto, is being furnished and shall not be deemed “filed” for the purposes of Section 18 of the Securities Exchange Act of 1934, as amended (the “Exchange Act”), or otherwise subject to the liabilities of that Section, nor shall it be deemed incorporated by reference in any filing made by the Company under the Securities Act of 1933, as amended, or the Exchange Act, except as otherwise set forth herein or as shall be expressly set forth by specific reference in such a filing.

1 

EXHIBIT INDEX

Exhibit No.		Description
99.1		Press release dated December 18, 2025.

2 

SIGNATURES

Pursuant to the requirements of the Securities Exchange Act of 1934, as amended, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.

	Alpha Tau Medical Ltd.
Date: December 18, 2025	By:	/s/ Uzi Sofer
		Uzi Sofer
		Chief Executive Officer

3 

FAQ

What does Alpha Tau Medical Ltd. (DRTS) disclose in this Form 6-K?

The company reports that it issued a press release titled “Alpha Tau to Present at the J.P. Morgan 2026 Healthcare Conference,” dated December 18, 2025, and attaches it as Exhibit 99.1.

What is Exhibit 99.1 in Alpha Tau Medical Ltd. (DRTS) December 2025 Form 6-K?

Exhibit 99.1 is a press release dated December 18, 2025, titled “Alpha Tau to Present at the J.P. Morgan 2026 Healthcare Conference.”

Is the information in this Alpha Tau Medical Ltd. (DRTS) Form 6-K considered filed or furnished?

The company states that the information in this Form 6-K, including Exhibit 99.1, is being furnished and shall not be deemed filed for purposes of Section 18 of the Exchange Act.

Can the information in this Alpha Tau Medical Ltd. (DRTS) Form 6-K be incorporated by reference into other filings?

The company explains that the information will not be incorporated by reference into Securities Act or Exchange Act filings, unless expressly set forth by specific reference in such a filing.

Who signed this Form 6-K for Alpha Tau Medical Ltd. (DRTS)?

The report was signed on behalf of Alpha Tau Medical Ltd. by Uzi Sofer, Chief Executive Officer, dated December 18, 2025.

Does this Alpha Tau Medical Ltd. (DRTS) Form 6-K include financial results or earnings data?

No, this report only references a press release about the company’s planned presentation at the J.P. Morgan 2026 Healthcare Conference and does not include financial or earnings information.